RDSN.F Stock Overview
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Redsense Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr1.05 |
| 52 Week High | kr1.05 |
| 52 Week Low | kr0.83 |
| Beta | 0.63 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 5.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| RDSN.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 0.6% |
| 1Y | n/a | -0.4% | 25.7% |
Return vs Industry: Insufficient data to determine how RDSN.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how RDSN.F performed against the US Market.
Price Volatility
| RDSN.F volatility | |
|---|---|
| RDSN.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.3% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: RDSN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RDSN.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 5 | Pontus Nobreus | redsensemedical.com |
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage.
Redsense Medical AB (publ) Fundamentals Summary
| RDSN.F fundamental statistics | |
|---|---|
| Market cap | US$7.87m |
| Earnings (TTM) | -US$427.06k |
| Revenue (TTM) | US$2.41m |
3.3x
P/S Ratio-18.4x
P/E RatioIs RDSN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RDSN.F income statement (TTM) | |
|---|---|
| Revenue | kr25.52m |
| Cost of Revenue | kr12.36m |
| Gross Profit | kr13.16m |
| Other Expenses | kr17.67m |
| Earnings | -kr4.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 51.56% |
| Net Profit Margin | -17.69% |
| Debt/Equity Ratio | 0% |
How did RDSN.F perform over the long term?
See historical performance and comparison